您的位置: 首页 > 农业专利 > 详情页

IMMUNOTHERAPEUTIC COMBINATIONS FOR THE TREATMENT OF TUMOURS THAT OVEREXPRESS GANGLIOSIDES
专利权人:
CENTRO DE IMMUNOLOGIA MOLECULAR
发明人:
申请号:
HU0401355
公开号:
HU0401355A3
申请日:
2002.04.08
申请国别(地区):
HU
年份:
2012
代理人:
摘要:
Chimeric antibody (A), derived from the monoclonal antibody P3, which recognizes N-glycosylated gangliosides and is produced by hybridoma ECACC 94113026, is new. Chimeric antibody (A), derived from the monoclonal antibody P3, which recognizes N-glycosylated gangliosides and is produced by hybridoma ECACC 94113026, has the following complementarity determining regions (CDR); for heavy chain: CDR1 (RYSVH); CDR2 (MIWGGGSTDYNSALKS) and CDR3 (SGVREGRAQAWFAY), and for the light chain: CDR1 (KASQDVSTAVA); CDR2 (SASYRYT) and CDR3 (QQHYSTPWT). Independent claims are also included for the following: (1) cell lines that produce (A); (2) chimeric monoclonal antibody (A') derived from the monoclonal antibody 1E10, which recognizes P3 and is produced by ECACC 97112901, having the CDRs: heavy chain: CDR1 (SYDIN); CDR2 (WIFPGDGSTKYNEKFKG) and CDR3 (EDYYDNSYYFDY), and light chain: CDR1 (RASQDISNYLN), CDR2 (YTSRLHSG), and CDR3 (QQGNTHPWT); and (3) cell lines that produce (A'). ACTIVITY : Cytostatic. No relevant biological data given. MECHANISM OF ACTION : Induction of a specific immune response. No relevant biological data given.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充